ghk-cu typical concentration for injection mg/ml 50mg 7% GHK-CU ACCELERANT - Platinum

Researched applications The published preclinical literature documents the effects of BPC-157 in the following areas (mostly in animal models): Tendon and ligament healing , Achilles tendon, medial collateral ligament (MCL, the ligament on the inner side of the knee), tendinopathy models Muscle injuries , quadriceps (front thigh), gastrocnemius (calf muscle), transections and contusions Bone and joint healing , osteoarthritis models, fracture healing, periodontal tissues (around the teeth) Gastrointestinal diseases , gastric lesions caused by alcohol or NSAIDs (ibuprofen, diclofenac), colitis, IBD models (Crohns disease), fistulas Hepatoprotection , protection of the liver against toxic damage (paracetamol overdose, CCl, alcohol) Vascular healing , endothelial dysfunction, thromboses, healing of vascular anastomoses after surgery, thrombocytopenia (low platelet count) Skin wounds , acute as well as diabetic wounds, burns Nerve regeneration , peripheral (sciatic nerve crush) as well as central (cerebral ischemia models, i.e

This injection is primarily prescribed for individuals with neuropathy, pernicious anemia, and certain types of anemia caused by B12 deficiency

Kuchakulla M, Masterson T, Arora H, Kulandavelu S, Ramasamy R

Knowing that 1 ml equals 1,000 mcg is critical

The benefits of Neuroswift Injection 1ml are derived from correcting the underlying B12 deficiency, which leads to improved neurological and haematological health